2009
DOI: 10.1111/j.1365-2990.2008.00961.x
|View full text |Cite
|
Sign up to set email alerts
|

Early transient presence of implanted bone marrow stem cells reduces lesion size after cerebral ischaemia in adult rats

Abstract: Early transient presence of implanted bone marrow stem cells reduces lesion size after cerebral ischaemia in adult ratsAims: Previous studies on the therapeutic time window for intravascular administration of bone marrow stem cells (BMSCs) after stroke have shown that early intervention (from 3 h after onset) in the middle cerebral artery occlusion (MCAO) rat model is the most effective approach to reduce ischaemic lesion size. We have confirmed these observations but noticed that 2 weeks after transplantation… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

7
58
1
1

Year Published

2009
2009
2018
2018

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 65 publications
(67 citation statements)
references
References 28 publications
7
58
1
1
Order By: Relevance
“…8,9 Furthermore, several studies have reported that transplanted BMSCs accelerate neuroplasticity and facilitate neuronal regeneration, as well as functional recovery. [10][11][12][13][14] Therefore, BMSC therapy may be a novel method to repair brain lesions and promote patients with functional disorders after severe TBI. Here, we report our experiences with autologous BMSC transplant that we have used in a clinical trial for patients with TBI complications.…”
Section: Introductionmentioning
confidence: 99%
“…8,9 Furthermore, several studies have reported that transplanted BMSCs accelerate neuroplasticity and facilitate neuronal regeneration, as well as functional recovery. [10][11][12][13][14] Therefore, BMSC therapy may be a novel method to repair brain lesions and promote patients with functional disorders after severe TBI. Here, we report our experiences with autologous BMSC transplant that we have used in a clinical trial for patients with TBI complications.…”
Section: Introductionmentioning
confidence: 99%
“…Recently, there has been increasing interest in the study in which injured neural components were replaced by BMSCs that can be easily isolated from small aspirates of bone marrow and expanded in culture (Hofstetter et al 2002;Shimizu et al 2007;Keimpema et al 2009). …”
Section: Discussionmentioning
confidence: 99%
“…Currently, there are several methods for the induction of differentiation of MSCs into neural cells: (1) exposure to inducing cytokine and neurotrophic factors, such as NGF, GDNF, and EGF (Low et al 2008;Cohen et al 2011;Keimpema et al 2009 exposure to chemical inducers such as b-mercaptoethanol, DMSO, and glutathione (Woodbury et al 2000;Kang et al 2006;Sagara and Makino 2008); (3) a combination of cytokines and chemical inducers; (4) other methods including exposure to traumatic brain homogenate, co-culture in or exposure to culture medium/Chinese medicines (Yong et al 2008;Wang et al 2009). Differentiation of MSC to neuron-like cells was firstly reported by Woodbury et al (2000), but increasing researches found that chemical inducers had negative effects on viability of MSC during induction in vitro.…”
Section: Discussionmentioning
confidence: 99%
“…Удаление селезенки или ее облучение перед или сразу после окклю-зии мозговой артерии уменьшает размеры ише-мического инфаркта и улучшает восстановление [90,137]. В этом аспекте терапевтический потен-циал стволовых клеток в моделях ишемического поражения головного мозга может быть в значи-тельной мере опосредован их способностью по-давлять провоспалительный ответ со стороны се-лезенки [56,108,142].…”
Section: системные проявления иммунного ответа на острую ишемиюunclassified